SPA
PAHC icon

Sherbrooke Park Advisers’s Phibro Animal Health PAHC Stock Holding History

Sherbrooke Park Advisers’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-9,240
Closed -$236K – 669
2025
Q2 		$236K Buy
+9,240
New +$201K 0.1% 353
2024
Q1 		– Sell
-12,055
Closed -$140K – 959
2023
Q4 		$140K Buy
+12,055
New +$136K 0.07% 369

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sherbrooke Park Advisers's PAHC Position: Q3 2025 in Review

Sherbrooke Park Advisers sold out of Phibro Animal Health (PAHC) in Q3 2025, closing a stake of 9,240 shares — an estimated $236K sold.

Sherbrooke Park Advisers first reported a position in PAHC in Q4 2023 and held it in 2 quarters. The position peaked at $236K in Q2 2025. 218 funds tracked by Wall St. Rank hold PAHC as of Q3 2025.

  • Sherbrooke Park Advisers reported no remaining Phibro Animal Health position as of Q3 2025 after selling out during the quarter.
  • Sherbrooke Park Advisers sold 9,240 Phibro Animal Health shares in Q3 2025, an estimated $236K.
  • Sherbrooke Park Advisers first reported a position in Phibro Animal Health in Q4 2023 and held it in 2 quarters.
  • Sherbrooke Park Advisers's Phibro Animal Health position peaked at $236K in Q2 2025.
  • 218 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.